185 related articles for article (PubMed ID: 20977419)
21. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects.
Du J; Cheng B; Zhu X; Ling C
J Immunol; 2011 Jul; 187(2):942-50. PubMed ID: 21666059
[TBL] [Abstract][Full Text] [Related]
22. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.
Vayssière BM; Dupont S; Choquart A; Petit F; Garcia T; Marchandeau C; Gronemeyer H; Resche-Rigon M
Mol Endocrinol; 1997 Aug; 11(9):1245-55. PubMed ID: 9259316
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of glucocorticoids: beyond receptors.
van der Laan S; Meijer OC
Eur J Pharmacol; 2008 May; 585(2-3):483-91. PubMed ID: 18410913
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
Kleiman A; Tuckermann JP
Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory glucocorticoids: changing concepts.
Newton R
Eur J Pharmacol; 2014 Feb; 724():231-6. PubMed ID: 23747654
[TBL] [Abstract][Full Text] [Related]
26. The long winding road to the safer glucocorticoid receptor (GR) targeting therapies.
Lesovaya EA; Chudakova D; Baida G; Zhidkova EM; Kirsanov KI; Yakubovskaya MG; Budunova IV
Oncotarget; 2022; 13():408-424. PubMed ID: 35198100
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism of action of glucocorticoids in asthma].
Jaffuel D; Mathieu M; Godard P; Michel FB; Demoly P
Rev Mal Respir; 1999 Sep; 16(4):431-42. PubMed ID: 10549054
[TBL] [Abstract][Full Text] [Related]
28. JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits improved transrepression/transactivation dissociation.
Kurimoto T; Tamai I; Miyai A; Kosugi Y; Nakagawa T; Yamamoto Y; Deai K; Misaki S; Bessho Y; Negoro T; Yamaguchi T; Hata T; Matsushita M
Eur J Pharmacol; 2017 May; 803():179-186. PubMed ID: 28366807
[TBL] [Abstract][Full Text] [Related]
29. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.
Ingawale DK; Mandlik SK; Patel SS
J Complement Integr Med; 2015 Mar; 12(1):1-13. PubMed ID: 25503867
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel non-steroidal selective glucocorticoid receptor modulators by structure- and IGN-based virtual screening, structural optimization, and biological evaluation.
Hu X; Pang J; Chen C; Jiang D; Shen C; Chai X; Yang L; Zhang X; Xu L; Cui S; Hou T; Li D
Eur J Med Chem; 2022 Jul; 237():114382. PubMed ID: 35483323
[TBL] [Abstract][Full Text] [Related]
31. Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index.
Schäcke H; Rehwinkel H; Asadullah K
Curr Opin Investig Drugs; 2005 May; 6(5):503-7. PubMed ID: 15912964
[TBL] [Abstract][Full Text] [Related]
32. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
De Bosscher K; Beck IM; Haegeman G
Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Mechanisms of Glucocorticoids.
Vandewalle J; Luypaert A; De Bosscher K; Libert C
Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
[TBL] [Abstract][Full Text] [Related]
34. [Mechanisms of action of glucocorticoids].
Dejean C; Richard D
Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
[TBL] [Abstract][Full Text] [Related]
35. Recent developments in the discovery of selective glucocorticoid receptor modulators (SGRMs).
Hudson AR; Roach SL; Higuchi RI
Curr Top Med Chem; 2008; 8(9):750-65. PubMed ID: 18537686
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid receptor polymorphism affects transrepression but not transactivation.
van den Akker EL; Russcher H; van Rossum EF; Brinkmann AO; de Jong FH; Hokken A; Pols HA; Koper JW; Lamberts SW
J Clin Endocrinol Metab; 2006 Jul; 91(7):2800-3. PubMed ID: 16684836
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases.
Reeves EK; Rayavarapu S; Damsker JM; Nagaraju K
Endocr Metab Immune Disord Drug Targets; 2012 Mar; 12(1):95-103. PubMed ID: 22214335
[TBL] [Abstract][Full Text] [Related]
38. Negative glucocorticoid receptor response elements and their role in glucocorticoid action.
Dostert A; Heinzel T
Curr Pharm Des; 2004; 10(23):2807-16. PubMed ID: 15379669
[TBL] [Abstract][Full Text] [Related]
39. The glucocorticoid receptor in inflammatory processes: transrepression is not enough.
Hübner S; Dejager L; Libert C; Tuckermann JP
Biol Chem; 2015 Nov; 396(11):1223-31. PubMed ID: 25910399
[TBL] [Abstract][Full Text] [Related]
40. Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.
Lesovaya E; Yemelyanov A; Swart AC; Swart P; Haegeman G; Budunova I
Oncotarget; 2015 Oct; 6(31):30730-44. PubMed ID: 26436695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
